Study Summary
The purpose of this study is to evaluate the safety and efficiency of autologous CD19 CAR-T lymphocytes in a cohort of pediatric and young adult patients with relapsed /refractory B-lineage acute lymphoblastic leukemia
Want to learn more about this trial?
Request More InfoInterventions
Chimeric Antigen Receptor T-Cell TherapyBIOLOGICAL
anti-CD19 chimeric antigen receptor - transduced T-cell given IV
FludarabineDRUG
given IV
CyclophosphamideDRUG
given IV
TocilizumabDRUG
given IV
CytarabineDRUG
given IV
EtoposideDRUG
given IV
DexamethasoneDRUG
given IV
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology | Moscow | Russia |